Details of the Drug

General Information of Drug (ID: DM72YIS)

• Drug Name: SCYX-7158
• Synonyms: AN-2920; AN-3520; AN-5568; SCYX-6759; Trypanocidal compounds (human African trypanosomiasis); Oxaborole series (human African trypanosomiasis), SCYNEXIS/DNDi/Pace University/Anacor Pharmaceuticals; Trypanocidal compounds (human African trypanosomiasis), SCYNEXIS/DNDi/Pace University/Anacor Pharmaceuticals

Indication

Disease Entry	ICD 11	Status	REF
Trypanosomiasis	1D51-1F53	Phase 1	[1]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C17H14BF4NO3
  Canonical SMILES: B1(C2=C(C=CC(=C2)NC(=O)C3=C(C=C(C=C3)F)C(F)(F)F)C(O1)(C)C)O
  InChI: InChI=1S/C17H14BF4NO3/c1-16(2)12-6-4-10(8-14(12)18(25)26-16)23-15(24)11-5-3-9(19)7-13(11)17(20,21)22/h3-8,25H,1-2H3,(H,23,24)
  InChIKey: PTYGDEXEGLDNAZ-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 44178354
  CAS Number: 1266084-51-8
  UNII: 2IOR2OO3GW
  DrugBank ID: DB13086
  TTD ID: D07LYC
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] ClinicalTrials.gov (NCT01533961) Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158. U.S. National Institutes of Health.